Journal of Oncology Practice最新文献

筛选
英文 中文
Improving the Prevalence of HIV Testing Among Patients in a Gynecologic Oncology Department: Results of a Quality Improvement Project. 提高妇科肿瘤患者艾滋病毒检测的流行率:质量改进项目的结果。
Journal of Oncology Practice Pub Date : 2019-11-15 DOI: 10.1200/JOP.19.00382
Annamma Sam, J. George, Jolyn S. Taylor, J. Hwang, G. Chisholm, B. Granwehr, P. Soliman, K. Schmeler
{"title":"Improving the Prevalence of HIV Testing Among Patients in a Gynecologic Oncology Department: Results of a Quality Improvement Project.","authors":"Annamma Sam, J. George, Jolyn S. Taylor, J. Hwang, G. Chisholm, B. Granwehr, P. Soliman, K. Schmeler","doi":"10.1200/JOP.19.00382","DOIUrl":"https://doi.org/10.1200/JOP.19.00382","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900382"},"PeriodicalIF":0.0,"publicationDate":"2019-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00382","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65926683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An Unusual Case of Renal Cell Carcinoma Metastasis to Duodenum Presenting as Gastrointestinal Bleeding. 一例罕见的肾细胞癌转移至十二指肠,表现为胃肠道出血。
Journal of Oncology Practice Pub Date : 2019-11-13 DOI: 10.1200/JOP.19.00268
A. Munir, A. M. Khan, Lezah P. Mccarthy, S. Mehdi
{"title":"An Unusual Case of Renal Cell Carcinoma Metastasis to Duodenum Presenting as Gastrointestinal Bleeding.","authors":"A. Munir, A. M. Khan, Lezah P. Mccarthy, S. Mehdi","doi":"10.1200/JOP.19.00268","DOIUrl":"https://doi.org/10.1200/JOP.19.00268","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900268"},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00268","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46808365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Optic Neuritis Related to Atezolizumab Treatment in a Patient With Metastatic Non-Small-Cell Lung Cancer. 转移性非小细胞肺癌患者与Atezolizumab治疗相关的视神经炎
Journal of Oncology Practice Pub Date : 2019-11-13 DOI: 10.1200/JOP.19.00438
Nilay Sengul Samanci, Tuna Ozan, Emir Celik, F. Demi̇relli̇
{"title":"Optic Neuritis Related to Atezolizumab Treatment in a Patient With Metastatic Non-Small-Cell Lung Cancer.","authors":"Nilay Sengul Samanci, Tuna Ozan, Emir Celik, F. Demi̇relli̇","doi":"10.1200/JOP.19.00438","DOIUrl":"https://doi.org/10.1200/JOP.19.00438","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900438"},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00438","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43148971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Metastatic Sclerosing Mucoepidermoid Carcinoma With Eosinophilia. 转移性硬化性粘液表皮样癌伴嗜酸性粒细胞增多症。
Journal of Oncology Practice Pub Date : 2019-11-13 DOI: 10.1200/JOP.19.00211
B. Beutler, Mark B. Ulanja, Mohit Rishi, C. Elliott, Alastair E Moody, Kenneth G Konam, Nageshwara Gullapalli, T. Singh
{"title":"Metastatic Sclerosing Mucoepidermoid Carcinoma With Eosinophilia.","authors":"B. Beutler, Mark B. Ulanja, Mohit Rishi, C. Elliott, Alastair E Moody, Kenneth G Konam, Nageshwara Gullapalli, T. Singh","doi":"10.1200/JOP.19.00211","DOIUrl":"https://doi.org/10.1200/JOP.19.00211","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900211"},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00211","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49280961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged Survival With Reinstitution of High-Dose Chemotherapy With Peripheral Blood Stem-Cell Transplantation in a Patient With Refractory Testis Cancer. 顽固性睾丸癌患者重新接受大剂量化疗联合外周血干细胞移植延长生存期
Journal of Oncology Practice Pub Date : 2019-11-13 DOI: 10.1200/JOP.19.00361
M. Yan, N. Adra, L. Einhorn
{"title":"Prolonged Survival With Reinstitution of High-Dose Chemotherapy With Peripheral Blood Stem-Cell Transplantation in a Patient With Refractory Testis Cancer.","authors":"M. Yan, N. Adra, L. Einhorn","doi":"10.1200/JOP.19.00361","DOIUrl":"https://doi.org/10.1200/JOP.19.00361","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900361"},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00361","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43809122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Treatment of Cabozantinib-Related Palmar-Plantar Erythrodysesthesia With Topical Sildenafil, Diclofenac, and Gabapentin Cream: A Case Report. 局部西地那非、双氯芬酸和加巴喷丁乳膏治疗卡博替尼相关掌足底红肿:1例报告。
Journal of Oncology Practice Pub Date : 2019-11-13 DOI: 10.1200/JOP.19.00257
Kevin J Thai, Christopher Ralph, D. England
{"title":"Treatment of Cabozantinib-Related Palmar-Plantar Erythrodysesthesia With Topical Sildenafil, Diclofenac, and Gabapentin Cream: A Case Report.","authors":"Kevin J Thai, Christopher Ralph, D. England","doi":"10.1200/JOP.19.00257","DOIUrl":"https://doi.org/10.1200/JOP.19.00257","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900257"},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00257","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43838053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negotiating Lay and Clinical Issues: Implementing a Lay Navigation Program in Cancer Care. 谈判平躺和临床问题:在癌症护理中实施平躺导航计划。
Journal of Oncology Practice Pub Date : 2019-11-06 DOI: 10.1200/JOP.19.00339
Laura M. Holdsworth, Dani L. Zionts, Suwei Wang, D. Veruttipong, C. Brown-Johnson, S. Asch, E. Rosenthal, M. Winget
{"title":"Negotiating Lay and Clinical Issues: Implementing a Lay Navigation Program in Cancer Care.","authors":"Laura M. Holdsworth, Dani L. Zionts, Suwei Wang, D. Veruttipong, C. Brown-Johnson, S. Asch, E. Rosenthal, M. Winget","doi":"10.1200/JOP.19.00339","DOIUrl":"https://doi.org/10.1200/JOP.19.00339","url":null,"abstract":"PURPOSE\u0000Patients with cancer face daunting coordination problems at a vulnerable time. Lay navigation programs offer 1 approach to address these problems, but how to best implement these programs presents challenges. We sought to describe those implementation challenges at 1 academic cancer center to inform future efforts.\u0000\u0000\u0000METHODS\u0000We performed a mixed methods study using standard implementation outcomes 1 year after program initiation. Quantitative data from the electronic medical record and qualitative data from in-depth interviews, focus groups, and ethnographic observations were included in analyses. The study took place at a National Cancer Institute-designated comprehensive cancer center across 12 tumor-specific clinics.\u0000\u0000\u0000RESULTS\u0000Supportive care concerns, scheduling, and clinical-related issues were the most frequent issues navigators encountered. Effective navigation required continuous, time-consuming, invisible work, including building and maintaining a broad knowledge base of resources and health system processes, as well as cultivating relationships with diverse and changing clinical teams. The acceptability and appropriateness of lay navigator activities were mixed among clinic and social work staff, related to negotiating lines between clinical and nonclinical care.\u0000\u0000\u0000CONCLUSION\u0000After 1 year of implementation, lay navigators still found it difficult to interpret and prioritize complex patient needs in a way that all clinical staff found appropriate. Negotiating these issues has made it difficult to develop the strong relationships with clinical teams that are needed for an integrated approach to patient care. To successfully coordinate patient care, it seems that lay navigation programs should be integrated with clinical teams to provide more seamless patient care.","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900339"},"PeriodicalIF":0.0,"publicationDate":"2019-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00339","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43070241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Relevance of Anti-Galactose-α-1,3-Galactose Antibodies in the Era of Monoclonal Antibodies. 单克隆抗体时代抗半乳糖-α-1,3-半乳糖抗体的相关性。
Journal of Oncology Practice Pub Date : 2019-11-06 DOI: 10.1200/JOP.19.00445
A. Mangla, Nikki Agarwal
{"title":"Relevance of Anti-Galactose-α-1,3-Galactose Antibodies in the Era of Monoclonal Antibodies.","authors":"A. Mangla, Nikki Agarwal","doi":"10.1200/JOP.19.00445","DOIUrl":"https://doi.org/10.1200/JOP.19.00445","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900445"},"PeriodicalIF":0.0,"publicationDate":"2019-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00445","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42976773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Opioid Epidemic or Pain Crisis? Using the Virginia All Payer Claims Database to Describe Opioid Medication Prescribing Patterns and Potential Harms for Patients With Cancer. 阿片类药物流行还是疼痛危机?使用弗吉尼亚州所有付款人索赔数据库描述阿片类药物处方模式和对癌症患者的潜在危害。
Journal of Oncology Practice Pub Date : 2019-11-04 DOI: 10.1200/JOP.19.00149
Virginia T. LeBaron, F. Camacho, R. Balkrishnan, N. Yao, A. Gilson
{"title":"Opioid Epidemic or Pain Crisis? Using the Virginia All Payer Claims Database to Describe Opioid Medication Prescribing Patterns and Potential Harms for Patients With Cancer.","authors":"Virginia T. LeBaron, F. Camacho, R. Balkrishnan, N. Yao, A. Gilson","doi":"10.1200/JOP.19.00149","DOIUrl":"https://doi.org/10.1200/JOP.19.00149","url":null,"abstract":"PURPOSE\u0000A key challenge regarding the current opioid epidemic is understanding how concerns regarding opioid-related harms affect access to pain management, an essential element of cancer care. In certain regions of the United States where disproportionately high cancer mortality and opioid fatality rates coexist (such as southwest Virginia in central Appalachia), this dilemma is particularly pronounced.\u0000\u0000\u0000METHODS\u0000This longitudinal, exploratory, secondary analysis used the Commonwealth of Virginia All Payer Claims Database to describe prescription opioid medication (POM) prescribing patterns and potential harms for adult patients with cancer living in rural southwest Virginia between 2011 and 2015. Descriptive and inferential statistical analyses were conducted at the patient, prescriber, and prescription levels to identify patterns and predictors of POM prescribing and potential harms. To explore geographic patterns, choropleth and heat maps were created.\u0000\u0000\u0000RESULTS\u0000Of the total sample of patients with cancer (n = 4,324), less than 25% were prescribed a Controlled Substance Schedule II POM at least three times in any study year. More than 60% of patients never received a Controlled Substance Schedule II POM prescription. Six hundred fifty-two patients (15.1%) experienced 1,599 hospitalizations for any reason; 10 or fewer patients were admitted for 11 opioid use disorder-related hospitalizations. The main findings suggest potential undertreatment of cancer-related pain; no difference in risk for opioid-related hospitalization on the basis of frequency of POM prescriptions; and geographic disparities where opioid overdoses are occurring versus where POM prescription use is highest.\u0000\u0000\u0000CONCLUSION\u0000These findings have significant opioid policy and practice implications related to the need for cancer-specific prescribing guidelines, how to optimally allocate health delivery services, and the urgent need to improve data interoperability and access related to POMs.","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900149"},"PeriodicalIF":0.0,"publicationDate":"2019-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00149","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45724495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Management of Brain Metastases in Non-Small-Cell Lung Cancer. 非小细胞肺癌脑转移的治疗。
Journal of Oncology Practice Pub Date : 2019-11-01 DOI: 10.1200/JOP.19.00357
V. Ernani, T. Stinchcombe
{"title":"Management of Brain Metastases in Non-Small-Cell Lung Cancer.","authors":"V. Ernani, T. Stinchcombe","doi":"10.1200/JOP.19.00357","DOIUrl":"https://doi.org/10.1200/JOP.19.00357","url":null,"abstract":"Lung cancer is the leading cause of cancer-related death in the United States. Approximately 20% of these patients present with brain metastases (BMs). Surgical resection, stereotactic radiosurgery, and whole-brain radiation therapy have historically been the primary treatment modalities for patients with non-small-cell lung cancer (NSCLC) and BMs. The treatments for BMs have become complex with the discovery of targetable molecular drivers and the development of an astonishing number of tyrosine kinase inhibitors. Many of these tyrosine kinase inhibitors have robust and durable efficacy against CNS metastases. In many circumstances, these drugs can defer local therapy and even reduce the risk of CNS progression. More recently, immune checkpoint inhibitors have changed the treatment landscape for many patients with NSCLC; however, the role of immunotherapy in patients with BMs is the subject of ongoing investigations. This article will review the current data and our approach to patients with NSCLC and BMs.","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"15 11 1","pages":"563-570"},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00357","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42856429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信